|
RAPH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.62883073484954E-14 |
| Normal-vs-Stage2 |
4.22570001212819E-09 |
| Normal-vs-Stage3 |
9.53259693403652E-12 |
| Normal-vs-Stage4 |
1.97549998581792E-09 |
| Stage1-vs-Stage2 |
4.870600E-01 |
| Stage1-vs-Stage3 |
9.310600E-01 |
| Stage1-vs-Stage4 |
6.462000E-01 |
| Stage2-vs-Stage3 |
5.504800E-01 |
| Stage2-vs-Stage4 |
8.367200E-01 |
| Stage3-vs-Stage4 |
7.065800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.19744231092045E-14 |
| Normal-vs-AfricanAmerican |
1.239360E-04 |
| Normal-vs-Asian |
3.92740284738125E-11 |
| Caucasian-vs-AfricanAmerican |
6.554600E-01 |
| Caucasian-vs-Asian |
1.244200E-01 |
| AfricanAmerican-vs-Asian |
1.712990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.37185876179092E-12 |
| Normal-vs-Female |
1.62725388719309E-12 |
| Male-vs-Female |
8.857800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.67093030920296E-12 |
| Normal-vs-Age(41-60Yrs) |
3.04645197957143E-13 |
| Normal-vs-Age(61-80Yrs) |
1.43199896385227E-11 |
| Normal-vs-Age(81-100Yrs) |
1.207820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.465000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.934000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.436800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.032600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.771000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.344000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.358200E-01 |
| Classical-VS-Follicular |
8.540400E-02 |
| Classical-VS-Other |
3.458400E-01 |
| Classical-VS-Normal |
1.79056769411545E-12 |
| Tall-VS-Follicular |
2.176400E-01 |
| Tall-VS-Other |
2.842200E-01 |
| Tall-VS-Normal |
2.5522000002276E-07 |
| Follicular-VS-Other |
7.410200E-01 |
| Follicular-VS-Normal |
1.43970391164316E-11 |
| Other-VS-Normal |
6.777300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66133814775094E-16 |
| Normal-vs-N1 |
1.39089999962039E-07 |
| N0-vs-N1 |
2.740200E-01 |
|
|
